Review



tcn 213  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs tcn 213
    Tcn 213, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pmc12772459-34-0-6?v=Alomone+Labs
    Average 94 stars, based on 1 article reviews
    tcn 213 - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    96
    Cell Applications Inc t 75 flasks
    T 75 Flasks, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/bio_rxiv__64898__2026__04__03__716316-186-4-10?v=Cell+Applications+Inc
    Average 96 stars, based on 1 article reviews
    t 75 flasks - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    94
    Alomone Labs tcn 213
    Tcn 213, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pmc12772459-34-0-6?v=Alomone+Labs
    Average 94 stars, based on 1 article reviews
    tcn 213 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Philips Healthcare t scanners 215
    T Scanners 215, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pm41724485-72-25-28?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    t scanners 215 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    99
    Gilead Sciences fda approved car t cell 215 therapies
    Fda Approved Car T Cell 215 Therapies, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pm41376161-97-5-11?v=Gilead+Sciences
    Average 99 stars, based on 1 article reviews
    fda approved car t cell 215 therapies - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec t cell culture medium
    T Cell Culture Medium, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pmc11696065-362-23-18?v=Miltenyi+Biotec
    Average 96 stars, based on 1 article reviews
    t cell culture medium - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    Aduro Inc listeria infection lm δacta δinlb expressing tag- i epitope (sainnyaqkl, sv40 large t antigen206–215) (lmtag)
    Listeria Infection Lm δacta δinlb Expressing Tag I Epitope (Sainnyaqkl, Sv40 Large T Antigen206–215) (Lmtag), supplied by Aduro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pm39362791-89-14-24?v=Aduro+Inc
    Average 90 stars, based on 1 article reviews
    listeria infection lm δacta δinlb expressing tag- i epitope (sainnyaqkl, sv40 large t antigen206–215) (lmtag) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    92
    Jackson Immuno 215 t a b l e 2 primer sequences
    215 T A B L E 2 Primer Sequences, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/10__1096_slash_fj__202302265rr-88-103-99?v=Jackson+Immuno
    Average 92 stars, based on 1 article reviews
    215 t a b l e 2 primer sequences - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    90
    Aduro Inc lm δacta δinlb expressing tag-i epitope (sainnyaqkl, sv40 large t antigen 206–215 ) (lm tag)
    Early vaccination prevents liver tumor progression in AST;Cre-ER T2 mice. (A) Scheme: Early AST;Cre-ER T2 mice (42 days) were adoptively transferred with TCR <t>TAG</t> and left untreated (Φ) or the following day, immunized with empty LM (LMΦ) or LM expressing the TAG antigen (LM TAG ). One cohort (survival analysis) was followed to humane endpoint and the second (pre-endpoint analysis) analyzed at age 100 days prior to tumor endpoint. The † and numbers indicate the number of mice in the long-term cohort who reached humane endpoint and were euthanized. ( B ) Kaplan-Meier curve showing survival of mice in each group with n=5–6/treatment group. *p<0.05, **p<0.01 (log rank (Mantel-Cox) test). The ‡ indicates a mouse euthanized for endpoint of severe dermatitis, whereas all other mice were euthanized due to advanced liver tumors. ( C–F ) Cohort as in A was euthanized and analyzed at age 100 days prior to tumor endpoint. ( C ) Left, TCR TAG TNFα and IFNγ production after 4 hours ex vivo TAG peptide stimulation. Right, percentage of TCR TAG positive for IFNγ and TNFα/IFNγ. Each symbol represents an individual mouse with n=6–7/group. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( D ) Number of TCR TAG in spleen and livers. Each symbol represents an individual mouse with n=7–9/group. *p<0.05, ***p<0.001 (one-way ANOVA with post hoc Tukey test). ( E ) Left, histograms of TCR TAG PD1 expression. Right, percentage of PD1+TCR TAG with positive gate set to exclude naive TCR TAG (gray). Each symbol represents an individual mouse with n=2 for naive and n=7–9 for other groups. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( F ) Left, TCF1 and TOX expression in TCR TAG . Right, percentage of TCF1+TOX and TCF1-TOX+TCR TAG . Each symbol represents an individual mouse with n=8–9/group. *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA with post hoc Tukey test). C–F shows samples pooled from two independent experiments. ( G ) Early AST;Cre-ERT2 mice (42 days) were adoptively transferred with TCR TAG and immunized with LM TAG 7 days later (early LM TAG ) or 60 days later (at age 110 days) (late LM TAG ). Kaplan-Meier curve showing survival of mice in each group with n=5–8/treatment group. **p<0.01 (log rank (Mantel-Cox) test). ANOVA, analysis of variance; LM, Listeria monocytogenes.
    Lm δacta δinlb Expressing Tag I Epitope (Sainnyaqkl, Sv40 Large T Antigen 206–215 ) (Lm Tag), supplied by Aduro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pmc11459355-82-14-24?v=Aduro+Inc
    Average 90 stars, based on 1 article reviews
    lm δacta δinlb expressing tag-i epitope (sainnyaqkl, sv40 large t antigen 206–215 ) (lm tag) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Hugo Sachs Elektronik stimulator unit 215/t
    Early vaccination prevents liver tumor progression in AST;Cre-ER T2 mice. (A) Scheme: Early AST;Cre-ER T2 mice (42 days) were adoptively transferred with TCR <t>TAG</t> and left untreated (Φ) or the following day, immunized with empty LM (LMΦ) or LM expressing the TAG antigen (LM TAG ). One cohort (survival analysis) was followed to humane endpoint and the second (pre-endpoint analysis) analyzed at age 100 days prior to tumor endpoint. The † and numbers indicate the number of mice in the long-term cohort who reached humane endpoint and were euthanized. ( B ) Kaplan-Meier curve showing survival of mice in each group with n=5–6/treatment group. *p<0.05, **p<0.01 (log rank (Mantel-Cox) test). The ‡ indicates a mouse euthanized for endpoint of severe dermatitis, whereas all other mice were euthanized due to advanced liver tumors. ( C–F ) Cohort as in A was euthanized and analyzed at age 100 days prior to tumor endpoint. ( C ) Left, TCR TAG TNFα and IFNγ production after 4 hours ex vivo TAG peptide stimulation. Right, percentage of TCR TAG positive for IFNγ and TNFα/IFNγ. Each symbol represents an individual mouse with n=6–7/group. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( D ) Number of TCR TAG in spleen and livers. Each symbol represents an individual mouse with n=7–9/group. *p<0.05, ***p<0.001 (one-way ANOVA with post hoc Tukey test). ( E ) Left, histograms of TCR TAG PD1 expression. Right, percentage of PD1+TCR TAG with positive gate set to exclude naive TCR TAG (gray). Each symbol represents an individual mouse with n=2 for naive and n=7–9 for other groups. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( F ) Left, TCF1 and TOX expression in TCR TAG . Right, percentage of TCF1+TOX and TCF1-TOX+TCR TAG . Each symbol represents an individual mouse with n=8–9/group. *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA with post hoc Tukey test). C–F shows samples pooled from two independent experiments. ( G ) Early AST;Cre-ERT2 mice (42 days) were adoptively transferred with TCR TAG and immunized with LM TAG 7 days later (early LM TAG ) or 60 days later (at age 110 days) (late LM TAG ). Kaplan-Meier curve showing survival of mice in each group with n=5–8/treatment group. **p<0.01 (log rank (Mantel-Cox) test). ANOVA, analysis of variance; LM, Listeria monocytogenes.
    Stimulator Unit 215/T, supplied by Hugo Sachs Elektronik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pm38069238-339-5-8?v=Hugo+Sachs+Elektronik
    Average 90 stars, based on 1 article reviews
    stimulator unit 215/t - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Hugo Sachs Elektronik stimulator unit (215/t
    Early vaccination prevents liver tumor progression in AST;Cre-ER T2 mice. (A) Scheme: Early AST;Cre-ER T2 mice (42 days) were adoptively transferred with TCR <t>TAG</t> and left untreated (Φ) or the following day, immunized with empty LM (LMΦ) or LM expressing the TAG antigen (LM TAG ). One cohort (survival analysis) was followed to humane endpoint and the second (pre-endpoint analysis) analyzed at age 100 days prior to tumor endpoint. The † and numbers indicate the number of mice in the long-term cohort who reached humane endpoint and were euthanized. ( B ) Kaplan-Meier curve showing survival of mice in each group with n=5–6/treatment group. *p<0.05, **p<0.01 (log rank (Mantel-Cox) test). The ‡ indicates a mouse euthanized for endpoint of severe dermatitis, whereas all other mice were euthanized due to advanced liver tumors. ( C–F ) Cohort as in A was euthanized and analyzed at age 100 days prior to tumor endpoint. ( C ) Left, TCR TAG TNFα and IFNγ production after 4 hours ex vivo TAG peptide stimulation. Right, percentage of TCR TAG positive for IFNγ and TNFα/IFNγ. Each symbol represents an individual mouse with n=6–7/group. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( D ) Number of TCR TAG in spleen and livers. Each symbol represents an individual mouse with n=7–9/group. *p<0.05, ***p<0.001 (one-way ANOVA with post hoc Tukey test). ( E ) Left, histograms of TCR TAG PD1 expression. Right, percentage of PD1+TCR TAG with positive gate set to exclude naive TCR TAG (gray). Each symbol represents an individual mouse with n=2 for naive and n=7–9 for other groups. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( F ) Left, TCF1 and TOX expression in TCR TAG . Right, percentage of TCF1+TOX and TCF1-TOX+TCR TAG . Each symbol represents an individual mouse with n=8–9/group. *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA with post hoc Tukey test). C–F shows samples pooled from two independent experiments. ( G ) Early AST;Cre-ERT2 mice (42 days) were adoptively transferred with TCR TAG and immunized with LM TAG 7 days later (early LM TAG ) or 60 days later (at age 110 days) (late LM TAG ). Kaplan-Meier curve showing survival of mice in each group with n=5–8/treatment group. **p<0.01 (log rank (Mantel-Cox) test). ANOVA, analysis of variance; LM, Listeria monocytogenes.
    Stimulator Unit (215/T, supplied by Hugo Sachs Elektronik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t-215/pmc10706602-181-5-8?v=Hugo+Sachs+Elektronik
    Average 90 stars, based on 1 article reviews
    stimulator unit (215/t - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Early vaccination prevents liver tumor progression in AST;Cre-ER T2 mice. (A) Scheme: Early AST;Cre-ER T2 mice (42 days) were adoptively transferred with TCR TAG and left untreated (Φ) or the following day, immunized with empty LM (LMΦ) or LM expressing the TAG antigen (LM TAG ). One cohort (survival analysis) was followed to humane endpoint and the second (pre-endpoint analysis) analyzed at age 100 days prior to tumor endpoint. The † and numbers indicate the number of mice in the long-term cohort who reached humane endpoint and were euthanized. ( B ) Kaplan-Meier curve showing survival of mice in each group with n=5–6/treatment group. *p<0.05, **p<0.01 (log rank (Mantel-Cox) test). The ‡ indicates a mouse euthanized for endpoint of severe dermatitis, whereas all other mice were euthanized due to advanced liver tumors. ( C–F ) Cohort as in A was euthanized and analyzed at age 100 days prior to tumor endpoint. ( C ) Left, TCR TAG TNFα and IFNγ production after 4 hours ex vivo TAG peptide stimulation. Right, percentage of TCR TAG positive for IFNγ and TNFα/IFNγ. Each symbol represents an individual mouse with n=6–7/group. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( D ) Number of TCR TAG in spleen and livers. Each symbol represents an individual mouse with n=7–9/group. *p<0.05, ***p<0.001 (one-way ANOVA with post hoc Tukey test). ( E ) Left, histograms of TCR TAG PD1 expression. Right, percentage of PD1+TCR TAG with positive gate set to exclude naive TCR TAG (gray). Each symbol represents an individual mouse with n=2 for naive and n=7–9 for other groups. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( F ) Left, TCF1 and TOX expression in TCR TAG . Right, percentage of TCF1+TOX and TCF1-TOX+TCR TAG . Each symbol represents an individual mouse with n=8–9/group. *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA with post hoc Tukey test). C–F shows samples pooled from two independent experiments. ( G ) Early AST;Cre-ERT2 mice (42 days) were adoptively transferred with TCR TAG and immunized with LM TAG 7 days later (early LM TAG ) or 60 days later (at age 110 days) (late LM TAG ). Kaplan-Meier curve showing survival of mice in each group with n=5–8/treatment group. **p<0.01 (log rank (Mantel-Cox) test). ANOVA, analysis of variance; LM, Listeria monocytogenes.

    Journal: Journal for Immunotherapy of Cancer

    Article Title: Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control

    doi: 10.1136/jitc-2024-009129

    Figure Lengend Snippet: Early vaccination prevents liver tumor progression in AST;Cre-ER T2 mice. (A) Scheme: Early AST;Cre-ER T2 mice (42 days) were adoptively transferred with TCR TAG and left untreated (Φ) or the following day, immunized with empty LM (LMΦ) or LM expressing the TAG antigen (LM TAG ). One cohort (survival analysis) was followed to humane endpoint and the second (pre-endpoint analysis) analyzed at age 100 days prior to tumor endpoint. The † and numbers indicate the number of mice in the long-term cohort who reached humane endpoint and were euthanized. ( B ) Kaplan-Meier curve showing survival of mice in each group with n=5–6/treatment group. *p<0.05, **p<0.01 (log rank (Mantel-Cox) test). The ‡ indicates a mouse euthanized for endpoint of severe dermatitis, whereas all other mice were euthanized due to advanced liver tumors. ( C–F ) Cohort as in A was euthanized and analyzed at age 100 days prior to tumor endpoint. ( C ) Left, TCR TAG TNFα and IFNγ production after 4 hours ex vivo TAG peptide stimulation. Right, percentage of TCR TAG positive for IFNγ and TNFα/IFNγ. Each symbol represents an individual mouse with n=6–7/group. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( D ) Number of TCR TAG in spleen and livers. Each symbol represents an individual mouse with n=7–9/group. *p<0.05, ***p<0.001 (one-way ANOVA with post hoc Tukey test). ( E ) Left, histograms of TCR TAG PD1 expression. Right, percentage of PD1+TCR TAG with positive gate set to exclude naive TCR TAG (gray). Each symbol represents an individual mouse with n=2 for naive and n=7–9 for other groups. **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA with post hoc Tukey test). ( F ) Left, TCF1 and TOX expression in TCR TAG . Right, percentage of TCF1+TOX and TCF1-TOX+TCR TAG . Each symbol represents an individual mouse with n=8–9/group. *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA with post hoc Tukey test). C–F shows samples pooled from two independent experiments. ( G ) Early AST;Cre-ERT2 mice (42 days) were adoptively transferred with TCR TAG and immunized with LM TAG 7 days later (early LM TAG ) or 60 days later (at age 110 days) (late LM TAG ). Kaplan-Meier curve showing survival of mice in each group with n=5–8/treatment group. **p<0.01 (log rank (Mantel-Cox) test). ANOVA, analysis of variance; LM, Listeria monocytogenes.

    Article Snippet: LM ΔactA ΔinlB expressing Tag-I epitope (SAINNYAQKL, SV40 large T antigen 206–215 ) (LM TAG ), or without exogenous antigens (LMΦ), were generated by Aduro Biotech and stored at −80°C.

    Techniques: Expressing, Ex Vivo